Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

SHOCKING: Merck co s quarterly earnings preview what you need to know - What They Never Told You

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $304.5 billion, the company is expected to release its Q1 2026 earnings on Thursday, Apr. 30, before the market opens.

Ahead of the event, analysts expect the company’s loss per share to be $0.58 on a diluted basis, down 126.1% from $2.22 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.